Tucker Asset Management LLC Novavax Inc Transaction History

Tucker Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$5.76 - $12.48 $984 - $2,134	-171 Closed	0 $0
Q4 2022 May 11, 2023	SELL	$8.86 - $25.04 $1,515 - $4,281	-171 Closed	0 $0
Q1 2022 May 11, 2023	BUY	$69.73 - $142.9 $11,923 - $24,435	171 New	171 $12.6 Million
Q4 2021 May 11, 2023	BUY	$134.56 - $217.97 $23,009 - $37,272	171 New	171 $26.5 Million
Q3 2021 Aug 10, 2023	BUY	$177.8 - $270.58 $30,403 - $46,269	171 New	171 $25.5 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Tucker Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tucker Asset Management LLC with notifications on news.